BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1978425)

  • 1. Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals.
    Mytilineos J; Scherer S; Opelz G
    Transplantation; 1990 Nov; 50(5):870-3. PubMed ID: 1978425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class II DNA-RFLP typing in 102 individuals from Northern Greece.
    Adam K; Vavatsi N; Mytilineos J; Kouidou S; Polymenidis Z; Trakatellis A; Opelz G
    Transpl Int; 1994; 7 Suppl 1():S522-6. PubMed ID: 11271298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA HLA-DR typing results of 4000 kidney transplants.
    Mytilineos J; Scherer S; Dunckley H; Trejaut J; Chapman J; Fischer G; Fae I; Middleton D; Savage D; Bignon JD
    Transplantation; 1993 Apr; 55(4):778-81. PubMed ID: 8097342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.
    Olerup O; Zetterquist H
    Tissue Antigens; 1992 May; 39(5):225-35. PubMed ID: 1357775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of HLA-DR oligotyping to 110 kidney transplant patients with doubtful serological typing.
    Tiercy JM; Goumaz C; Mach B; Jeannet M
    Transplantation; 1991 May; 51(5):1110-4. PubMed ID: 1674388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DRB and DQB typing by a combination of serology, restriction fragment length polymorphism analysis and oligonucleotide probing.
    Doherty DG; Donaldson PT
    Eur J Immunogenet; 1991; 18(1-2):111-24. PubMed ID: 1676909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serological and molecular (PCR-SSP) techniques of HLA-DR typing in clinical laboratory routine.
    Woszczek G; Borowiec M; Miś M; Górska M; Kowalski ML
    Ann Transplant; 1997; 2(1):39-42. PubMed ID: 9869840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA typing: an important step forward? Collaborative Transplant Study.
    Opelz G; Mytilineos J; Scherer S; Dunckley H; Trejaut J; Chapman J; Middleton D; Savage D; Fischer G; Bignon JD; Bensa JC; Albert E; Noreen H
    Transpl Int; 1992; 5 Suppl 1():S580-2. PubMed ID: 14628739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR and DQ matching by DNA restriction fragment length polymorphism methods and the outcome of mixed lymphocyte reaction tests in unrelated bone marrow donor searches. The IMUST Study.
    Howard MR; Brookes P; Bidwell JL; Bidwell EA; Clay TM; Evans JL; Hows JM; Bradley BA
    Bone Marrow Transplant; 1992 Mar; 9(3):161-6. PubMed ID: 1354994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR typing of renal allograft patients and donors by DNA-RFLP: correlation with pretransplant serotyping.
    Wood N; Joysey V; Bidwell J; Klouda P
    Transplant Proc; 1990 Oct; 22(5):2287. PubMed ID: 1977225
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of serological, cellular and DNA-RFLP methods for HLA matching in the selection of related bone marrow donors.
    Howell WM; Evans PR; Spellerberg MB; Wilson PJ; Smith JL
    Bone Marrow Transplant; 1989 Jan; 4(1):63-8. PubMed ID: 2522330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single center evaluation of the Collaborative Transplant Study (CTS) DNA project.
    Emonds MP; Mytilineos Y; Scherer S; Waer M; Vanrenterghem Y; Opelz G; Dendievel J; Vermylen C
    Transpl Int; 1996; 9(5):468-75. PubMed ID: 8875789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HLA-DR typing by standard serology and PCR-amplification with sequence-specific primers: a comparative study].
    Tan J; Xie T; Xu Q
    Zhonghua Yi Xue Za Zhi; 1997 Jan; 77(1):28-30. PubMed ID: 9596973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of DNA HLA-DR typed and matched cadaver kidney transplants. The Collaborative Transplant Study.
    Opelz G; Mytilineos J; Scherer S; Dunckley H; Trejaut J; Chapman J; Middleton D; Savage D; Fischer O; Bignon JD
    Lancet; 1991 Aug; 338(8765):461-3. PubMed ID: 1678443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RFLP-DR beta and serological HLA-DR typing of 200 kidney recipients and 1000 controls.
    Mytilineos J; Scherer S; Hansen B; Gaweco A; Opelz G
    Transplant Proc; 1990 Aug; 22(4):1911-2. PubMed ID: 1975140
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of typing results by serology and polymerase chain reaction with sequence-specific primers for HLA-Cw in 650 individuals.
    Mytilineos J; Christ U; Lempert M; Opelz G
    Tissue Antigens; 1997 Oct; 50(4):395-400. PubMed ID: 9349625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR typing using restriction fragment length polymorphism (RFLP) with one enzyme and two probes.
    Riisom K; Søorensen IJ; Møoller B; Kruse TA; Graugaard B; Lamm LU
    Tissue Antigens; 1988 Mar; 31(3):141-50. PubMed ID: 2897728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-RFLP analysis and genotyping of HLA-DR alleles in the south of Spain.
    Martín J; Almeida D; Mialdea MJ; Rodriguez M; Mataran L; Garrido F
    Exp Clin Immunogenet; 1991; 8(2):119-20. PubMed ID: 1686399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serological and DNA HLA-DR typing results for transplantation in Western Europe, Eastern Europe, North America and South America.
    Mytilineos J; Scherer S; Dunckley H; Chapman J; Middleton D; Opelz G
    Transpl Int; 1994; 7 Suppl 1():S519-21. PubMed ID: 11271296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of RFLP and PCR-ASO typing for HLA-DR-Dw and DQw typing.
    Bignon JD; Bidwell JL
    Eur J Immunogenet; 1991; 18(1-2):125-38. PubMed ID: 1676910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.